Fredun Pharmaceuticals Ltd. - Research Center
539730 FREDUN Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
142.71 |
116.97 |
122.57 |
99.17 |
45.33 |
Operating profit |
15.89 |
8.89 |
6.24 |
4.83 |
2.65 |
Interest |
5.51 |
3.77 |
2.97 |
1.69 |
1.68 |
Gross profit |
11.70 |
6.90 |
6.78 |
3.98 |
2.98 |
EPS (Rs) |
13.53 |
9.20 |
9.40 |
5.43 |
2.16 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
1.32 |
1.77 |
3.51 |
0.84 |
2.01 |
Stock adjustment |
-8.48 |
-2.01 |
23.55 |
-3.40 |
6.21 |
Raw material |
116.39 |
93.41 |
93.81 |
82.65 |
26.83 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
5.63 |
4.92 |
-15.95 |
4.53 |
4.06 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
13.28 |
11.76 |
14.92 |
10.56 |
5.57 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.85 |
1.38 |
1.13 |
1.02 |
0.96 |
Taxation |
3.51 |
1.42 |
1.48 |
0.79 |
- |
Net profit / loss |
6.34 |
4.10 |
4.17 |
2.17 |
0.86 |
Extra ordinary item |
- |
- |
- |
- |
-1.16 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.68 |
4.45 |
4.43 |
3.99 |
3.99 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
11.14 |
7.60 |
5.09 |
4.87 |
5.85 |
GPM (%) |
8.13 |
5.81 |
5.38 |
3.98 |
6.30 |
NPM (%) |
4.40 |
3.45 |
3.31 |
2.17 |
1.82 |